News

(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Data shows that the two-dose measles vaccine is 97% effective at preventing measles and experts say protection doesn’t wane.
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
A measles outbreak in the state has not stopped “medical freedom” activists from pushing forward with their goal. They now ...
Recombinant zoster vaccine reduces all-cause mortality in patients with immune-mediated inflammatory diseases receiving Janus ...
Pigs could play a key role in ending the flu as we know it. That’s the message behind new research testing a ...